Cargando…

Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study

Background. Patients with Parkinson's disease (PD) have a high risk of cognitive problems. Objective. This study assesses whether abnormal echogenicity of the substantia nigra (SN) and raphe nuclei (RN) and the diameter of third ventricle are markers of cognitive impairment in patients with PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouwmans, Angela E. P., Leentjens, Albert F. G., Mess, Werner H., Weber, Wim E. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737005/ https://www.ncbi.nlm.nih.gov/pubmed/26881179 http://dx.doi.org/10.1155/2016/4058580

Ejemplares similares

Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients
por: Sadowski, Krzysztof, et al.
Publicado: (2011)

Raphe Nuclei Echogenicity and Diameter of Third Ventricle in Schizophrenia Measured by Transcranial Sonography
por: Mahdiar, Mahnoush, et al.
Publicado: (2023)

Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

Raphe nuclei echogenicity changes in major depression
por: Ghourchian, Shadi, et al.
Publicado: (2014)

The history of the research of iron in parkinsonian substantia nigra
por: Friedman, Andrzej, et al.
Publicado: (2012)

Raphe nuclei echogenicity changes in obsessive-compulsive disorder
por: Mohammadzade, Nahid, et al.
Publicado: (2018)

Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients
por: Bouwmans, Angela E P, et al.
Publicado: (2013)

Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson's Disease in Xinjiang
por: Wei, Rurui, et al.
Publicado: (2023)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
por: Dong, Zhi-Fen, et al.
Publicado: (2017)

Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients
por: Bouwmans, Angela E.P., et al.
Publicado: (2016)

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2005)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

Biochemical Changes Induced by Embryonic Substantia Nigra Transplanted to the Striatum of Parkinsonian Monkeys
por: Elsworth, J. D., et al.
Publicado: (1992)

Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson’s disease
por: Li, Kai, et al.
Publicado: (2020)

Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2006)

Echogenic alteration in the raphe nuclei measured by transcranial sonography in patients with Parkinson disease and depression
por: Liu, Xue Jiao, et al.
Publicado: (2018)

Increased Ndfip1 in the Substantia Nigra of Parkinsonian Brains Is Associated with Elevated Iron Levels
por: Howitt, Jason, et al.
Publicado: (2014)

Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson’s disease: a Chinese population-based study
por: Li, Ting, et al.
Publicado: (2019)

Reduced midbrain raphe echogenicity in patients with fibromyalgia syndrome
por: Üçeyler, Nurcan, et al.
Publicado: (2022)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2021)

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
por: Yu, Shu-yang, et al.
Publicado: (2018)

Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin
por: Araújo, Nordeval Cavalcante, et al.
Publicado: (2022)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans
por: Todd, Gabrielle, et al.
Publicado: (2013)

Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI
por: Ahmadi, Seyed-Ahmad, et al.
Publicado: (2020)

Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance
por: Liu, Zhuo, et al.
Publicado: (2017)

Extracellular Nanomatrix‐Induced Self‐Organization of Neural Stem Cells into Miniature Substantia Nigra‐Like Structures with Therapeutic Effects on Parkinsonian Rats
por: Zhang, Shiqing, et al.
Publicado: (2019)

Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015)

Nicotine impact on rat substantia nigra compacta
por: Elgayar, Sanaa A M, et al.
Publicado: (2021)

Mesencephalic origin of the rostral Substantia nigra pars reticulata
por: Madrigal, M. Pilar, et al.
Publicado: (2015)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Enhanced training protects memory against amnesia produced by concurrent inactivation of amygdala and striatum, amygdala and substantia nigra, or striatum and substantia nigra
por: Salado-Castillo, Rigoberto, et al.
Publicado: (2011)

Echogenicity Changes in Brainstem Raphe Detected by Transcranial Parenchymal Sonography and Clinical Characteristics in Parkinson's Disease
por: Bei, Hong-Zhe, et al.
Publicado: (2020)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Bidirectional Modulation of Substantia Nigra Activity by Motivational State
por: Rossi, Mark A., et al.
Publicado: (2013)

Operant Self-Stimulation of Dopamine Neurons in the Substantia Nigra
por: Rossi, Mark A., et al.
Publicado: (2013)

Epstein-Barr virus encephalitis with substantia nigra involvement
por: Çelik, Tamer, et al.
Publicado: (2015)

Degeneration of the Substantia Nigra Following Ipsilateral Striatal Infarction
por: Ohtomo, Gaku, et al.
Publicado: (2017)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_anm0ms6p8j4r8npgemb4sut8kg